Peter Jones speaks at Nov. 21 Perspectives in Science seminar

Center News

Dr. Peter Jones, director of the USC/Norris Comprehensive Cancer Center in Los Angeles, will speak at a New Perspectives in Science seminar Tuesday, Nov. 21, at 4:30 p.m. in Pelton Auditorium. His presentation, "How the Epigenome Changes in Cancer," is the first of three presentations in the seminar series, which runs through April 2007.

Jones, a distinguished professor of Urology and Biochemistry and Molecular Biology at the Keck School of Medicine at the University of Southern California, is known for his studies on the molecular biology of cancer and of basic mechanisms of DNA methylation and its role in cancer and differentiation.

Jones will discuss the increasingly clear causative role that epigenetic silencing of tumor-suppressor genes plays in human carcinogenesis. Reversing chromatin structural changes, including DNA methylation, histone modification and nucleosomal, are occupancy important targets for epigenetic therapy. The role of epigenetic therapy in cancer therapeutics and prevention is likely to become more pronounced over the next few years.

In 1980, Jones made a seminal discovery that the drug 5-azacytidine could induce profound changes in gene expression while being a powerful inhibitor of DNA methylation. This discovery was the first to causally link DNA cytosine methylation, differentiation and gene expression, and played a large part in launching the field of epigenetics. While this seminar series is open to all, the content is often scientifically technical.

Dr. Denise Galloway of the Human Biology Division will speak at the second seminar Feb. 15, followed by Dr. Shirley Ann Jackson April 12. While this seminar series is open to all, the content is often scientifically technical.

Center News Table of Contents